Scherer J
Bezirkskrankenhaus Haar, Germany.
Adv Ther. 1998 Jul-Aug;15(4):261-9.
Fifty-two outpatients suffering from anxiety of nonpsychotic origin were included in an observational study of a kava-kava preparation. Drug efficacy was evident on measures of a global improvement scale, with 42 patients (80.8%) rating treatment as "very good" or "good". Adverse events were rare. These results support kava-kava extract as an effective and safe alternative to antidepressants and tranquilizers in anxiety disorder without the tolerance problems associated with benzodiazepines.
52名患有非精神病性焦虑症的门诊患者被纳入一项关于卡瓦提取物制剂的观察性研究。在整体改善量表的测量中,药物疗效显著,42名患者(80.8%)将治疗评为“非常好”或“好”。不良事件很少见。这些结果支持卡瓦提取物可作为治疗焦虑症的一种有效且安全的替代抗抑郁药和镇静剂的药物,且不存在与苯二氮䓬类药物相关的耐受性问题。